Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Mitsubishi To Buy Japan’s Qualicaps
by Michael McCoy
January 7, 2013
| A version of this story appeared in
Volume 91, Issue 1
Mitsubishi Chemical Holdings has agreed to pay about $640 million for Qualicaps, a Japan-based producer of gelatin and cellulose capsules for drug and nutritional products. The seller is the private equity firm Carlyle Group, which acquired Qualicaps from the Japanese drug firm Shionogi in 2005. The parties expect Qualicaps to post 2012 sales of about $220 million. Mitsubishi says Qualicaps will complement its active pharmaceutical ingredients business. Mitsubishi also expects to apply its own know-how in resin processing and cellulose-based materials.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X